WithdrawnNot Applicable

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

Stopped: Not able to recruit subjects

Spain0Started 2020-05-01

Plain-language summary

The COVID-19 Androgen Sensitivity Test is a non-invasive In-Vitro Diagnostic device that utilizes Next Generation Sequencing Technology (NGS). The results of the test are used by a physician to assess the risk of developing severe symptoms following COVID-19 infection, The COVID-19 Androgen Sensitivity Test requires a health care professional to collect a DNA sample using an FDA cleared DNA sample collection kit.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Male over the age of 18 * First time present at the site * Laboratory confirmed SARS-CoV-2 infection * Able to give informed consent Exclusion Criteria: * Unable to give informed consent * Diagnosed with an additional respiratory co-infection * XXY males

What they're measuring

Hospital-free days to Day 28 [ Time Frame: 28 days]

Timeframe: 28 days

1. Severity of Disease

Timeframe: Day 28

Trial details

NCT IDNCT04368897

SponsorApplied Biology, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-12-01

View on ClinicalTrials.gov More SARS-CoV 2 trials